Increased vulnerability with aging to MPTP: The mechanisms underlying mitochondrial dynamics

Neurological Research

Volumn 36, Issue 8, 2014, Pages 722-732

  Jiang, Ning ^a   Bo, Hai ^a,b   Song, Chao ^a   Guo, Jingjing ^a   Zhao, Fei ^a   Feng, Hong ^a   Ding, Hu ^a   Ji, Lili ^a,c   Zhang, Yong ^a  

^a TIANJIN UNIVERSITY OF SPORT   (China)

^b Department of Military Training Medicines Logistics University of Chinese People's Armed Police Force   (China)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Aging; Increased vulnerability; Mitochondrial dynamics; Parkinson's disease

Indexed keywords

1, 2, 3, 6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; FACTOR FOR INVERSION STIMULATION; MITOFUSIN 2; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

AGING; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; MALE; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; PARKINSON DISEASE; PATHOLOGY; SUBSTANTIA NIGRA; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; ANIMAL; AUTOPHAGY; C57BL MOUSE; DRUG EFFECTS; INTOXICATION; METABOLISM; MITOCHONDRION; PHYSIOLOGY; ULTRASTRUCTURE;

AGING; ANIMALS; AUTOPHAGY; MALE; MICE; MICE, INBRED C57BL; MITOCHONDRIA; MITOCHONDRIAL DYNAMICS; MPTP POISONING; PARKINSON DISEASE; REACTIVE OXYGEN SPECIES; SUBSTANTIA NIGRA;

EID: 84903719279     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132813Y.0000000296     Document Type: Article

References (34)

1. Lin TK, Liou CW, Chen SD, Chuang YC, Tiao MM, Wang PW, et al. Mitochondrial dysfunction and biogenesis in the pathogenesis of Parkinson's disease. Chang Gung Med J. 2009;32:589-99.
2. Silver D. Impact of functional age on the use of dopamine agonists in patients with Parkinson disease. Neurologist. 2006;12:214-23.
3. Arduino DM, Esteves AR, Cardoso SM. Mitochondrial fusion/ fission, transport and autophagy in Parkinson's disease: when mitochondria get nasty. Parkinsons Dis. 2011;2011:767230
4. Shapiro MA, Chang YL, Munson SK, Jacobson CE, Rodriguez RL, Skidmore FM, et al. The four as associated with pathological Parkinson disease gamblers: anxiety, anger, age, and agonists. Neuropsychiatr Dis Treat. 2007;3:161-7.
5. Fahn S, Oakes D, Shoulson I, Kieburtz K, Rudolph A, Lang A, et al. Levodopa and the progression of Parkinson's disease. N Engl J Med. 2004;351:2498-508.
6. Campdelacreu J. Parkinson disease and Alzheimer disease: environmental risk factors. Neurologia. 2012 June 13 [epub ahead of print].
7. Greenbaum L, Tegeder I, Barhum Y, Melamed E, Roditi Y, Djaldetti R. Contribution of genetic variants to pain susceptibility in Parkinson disease. Eur J Pain. 2012;16:1243-50.
8. Levy G. The relationship of Parkinson disease with aging. Arch Neurol. 2007;64:1242-6.
9. Diederich NJ, Moore CG, Leurgans SE, Chmura TA, Goetz CG Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset. Arch Neurol. 2003;60:529-33.
10. Twig G, Hyde B, Shirihai OS. Mitochondrial fusion, fission and autophagy as a quality control axis: the bioenergetic view. Biochim Biophys Acta. 2008;1777:1092-7.
11. Schapira AH, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD. Mitochondrial complex I deficiency in Parkinson's disease. Lancet. 1989;1:1269.
12. Matsuura K, Kabuto H, Makino H, Ogawa N. Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion. J Neurosci Methods. 1997;73:45-8.
13. Wang X, Leverin AL, Han W, Zhu C, Johansson BR, Jacotot E, et al. Isolation of brain mitochondria from neonatal mice. J Neurochem. 2011;119:1253-61.
14. Bo H, Jiang N, Ma G, Qu J, Zhang G, Cao D, et al. Regulation of mitochondrial uncoupling respiration during exercise in rat heart: role of reactive oxygen species (ROS) and uncoupling protein 2. Free Radic Biol Med. 2008;44:1373-81.
15. Jiang N, Zhang G, Bo H, Qu J, Ma G, Cao D, et al. Upregulation of uncoupling protein-3 in skeletal muscle during exercise: a potential antioxidant function. Free Radic Biol Med. 2009;46:138-45.
16. Levy G, Louis ED, Cote L, Perez M, Mejia-Santana H, Andrews H, et al. Contribution of aging to the severity of different motor signs in Parkinson disease. Arch Neurol. 2005;62:467-72.
17. Ghebremedhin E, Del Tredici K, Vuksic M, Rub U, Thal DR, Burbach GJ, et al. Relationship of apolipoprotein E and age at onset to Parkinson disease neuropathology. J Neuropathol Exp Neurol. 2006;65:116-23.
18. Cawthon D, Beers K, Bottje WG Electron transport chain defect and inefficient respiration may underlie pulmonary hypertension syndrome (ascites)-associated mitochondrial dysfunction in broilers. Poult Sci. 2001;80:474-84.
19. Brand MD, Chien LF, Ainscow EK, Rolfe DF, Porter RK. The causes and functions of mitochondrial proton leak. Biochim Biophys Acta. 1994;1187:132-9.
20. Lockwood AH. Pesticides and parkinsonism: is there an etiological link? Curr Opin Neurol. 2000;13:687-90.
21. Gao HM, Liu B, Zhang W, Hong JS. Novel anti-inflammatory therapy for Parkinson's disease. Trends Pharmacol Sci. 2003;24:395-401.
22. Bueler H. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease. Exp Neurol. 2009;218:235-46.
23. Sanchez-Roman I, Gomez A, Perez I, Sanchez C, Suarez H, Naudí A, et al. Effects of aging and methionine restriction applied at old age on ROS generation and oxidative damage in rat liver mitochondria. Biogerontology. 2012;13:399-411.
24. Lores-Arnaiz S, Bustamante J. Age-related alterations in mitochondrial physiological parameters and nitric oxide production in synaptic and non-synaptic brain cortex mitochondria. Neuroscience. 2011;188:117-24.
25. Arthur CR, Morton SL, Dunham LD, Keeney PM, Bennett JP Jr. Parkinson's disease brain mitochondria have impaired respirasome assembly, age-related increases in distribution of oxidative damage to mtDNA and no differences in hetero-plasmic mtDNA mutation abundance. Mol Neurodegener. 2009;4:37.
26. Chan DC. Mitochondria: dynamic organelles in disease, aging, and development. Cell. 2006;125:1241-52.
27. Westermann B. Merging mitochondria matters: cellular role and molecular machinery of mitochondrial fusion. EMBO Rep. 2002;3:527-31.
28. Detmer SA, Chan DC. Functions and dysfunctions of mitochondrial dynamics. Nat Rev Mol Cell Biol. 2007;8:870-9.
29. Twig G, Elorza A, Molina AJ, Mohamed H, Wikstrom JD, Walzer G, et al. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J. 2008;27:433-46.
30. Suen DF, Norris KL, Youle RJ. Mitochondrial dynamics and apoptosis. Genes Dev. 2008;22:1577-90.
31. Rajawat YS, Bossis I. Autophagy in aging and in neurodegen-erative disorders. Hormones (Athens). 2008;7:46-61.
32. Nishino I. Autophagic vacuolar myopathies. Curr Neurol Neurosci Rep. 2003;3:64-9.
33. Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature. 1999;402:672-6.
34. Ghaemi M, Hilker R, Rudolf J, Sobesky J, Heiss WD. Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging. J Neurol Neurosurg Psychiatry. 2002;73:517-23.